How has COVID-19 impacted launch performance and timing?
Pharmaceutical leaders are facing some of the toughest challenges of their careers when it comes to launching in the midst of COVID-19. With so much at stake and so much uncertainty, companies are looking for fact-based insights to power their decision-making.
Trinity has done an in-depth evaluation of the impact of COVID-19 on launch performance and timing. We have compared forecasted/expected revenue to actual revenue for products that launched within six months of COVID-19. We have also explored products that received approval during COVID-19 but have had to delay launch.
Join us to hear the findings and get answers that will help you predict the impact on your product launches.
- Case studies of recently launched products that experienced significant challenges and successes through COVID-19
- Insights into the types of product and market factors that contributed to these successes and challenges
- A review of companies that delayed product launches and the impact of COVID-19 on expected FDA approval dates
Fill out the fields below to view “Webinar: COVID-19 Impact on Launch Performance.”
Sign up for the latest intelligence